Contract research organizations concept rises, Joinn Laboratories (06127) rises by 5.11%, institutions say CXO sector is expected to benefit from the recovery of overseas research and development demand.

Jinwu Financial News | The concept of contract research organizations has risen across the board, with joinn laboratories (06127) up 5.11%, tigermed (03347) up 4.33%, frontage (01521) up 2%, pharmaron (03759) up 1.84%, and wuxi bio (02269) up 0.79%. Zhongtai reported that the bank believes that as the medical insurance fund prepayment system continues to deepen and improve, and the supporting DRG/DIP system is continuously implemented in various provinces and cities, the long-term "triangle debt" relationship among hospitals, pharmaceutical companies, and medical insurance persists, and the "zero markup policy on pharmaceuticals" compresses hospital profitability.

Golden Guard Financial News21:46 ET

Trending Industry Today: WUXI APPTEC Leads Losses In CRO Stocks

Moomoo NewsNov 14 01:30 ET

WuXi Biologics Germany to Enhance Capabilities With New Prefilled Syringes Line

PR NewswireNov 13 23:00 ET

[Brokerage Focus] China Merchants maintains a "shareholding" rating for Wuxi Bio (02269), pointing to the expansion of the animal health biopharmaceutical field, which is expected to bring incremental performance.

Jingu Finance | China Merchants Securities issued a research report stating that wuxi bio (02269) announced the launch of PawBio animal health biopharmaceutical one-stop solution in early November. The firm believes that as a leading player in the human biopharmaceutical CDMO industry, with rich project experience, leading service quality, high customer recognition, expanding its business to the animal biopharmaceutical field could bring new business growth opportunities for the company. The firm also mentioned that with changes in family structures, pets have become increasingly important emotional support and daily companions for more and more people. Mars Inc. recently released the largest global pet survey report in terms of coverage and sample data.

Golden Guard Financial NewsNov 12 01:54 ET

Trump Government Likely to Still Pass Biosecure Act -- Market Talk

WSJNov 6 23:01 ET

Hong Kong stocks are active | CRO concepts generally rise, medical insurance negotiations support innovative drugs, and under the environment of interest rate cuts, global biomedical financing will rebound.

The concept of CRO is generally on the rise. As of the time of publication, Asymchem Laboratories (06821) rose by 4.95%, to HKD 59.4; Tigermed (03347) rose by 4.94%, to HKD 38.25; Wuxi Apptec (02359) rose by 3.88%, to HKD 53.5.

Zhitong FinanceNov 5 01:34 ET